Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Citius Pharmaceuticals Inc (NASDAQ: CTXR) closed at $0.79 down -9.66% from its previous closing price of $0.87. In other words, the price has decreased by -$9.66 from its previous closing price. On the day, 0.54 million shares were traded.
Ratios:
For a deeper understanding of Citius Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.06 and its Current Ratio is at 0.37. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
On November 30, 2021, Maxim Group started tracking the stock assigning a Buy rating and target price of $4.
Stock Price History:
Over the past 52 weeks, CTXR has reached a high of $26.25, while it has fallen to a 52-week low of $0.65. The 50-Day Moving Average of the stock is -7.19%, while the 200-Day Moving Average is calculated to be -82.97%.
Shares Statistics:
A total of 11.17M shares are outstanding, with a floating share count of 10.53M. Insiders hold about 5.74% of the company’s shares, while institutions hold 5.69% stake in the company.
